Cargando…

Targeting a novel cancer-driving protein (LAPTM4B-35) by a small molecule (ETS) to inhibit cancer growth and metastasis

Our previous studies demonstrated that LAPTM4B-35 is overexpressed in a variety of solid cancers including hepatocellular carcinoma (HCC), and is an independent factor for prognosis. LAPTM4B-35 overexpression causes carcinogenesis and enhances cancer growth, metastasis and multidrug resistance, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Maojin, Zhou, Rouli, Shan, Yi, Li, Li, Wang, Lin, Liu, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295449/ https://www.ncbi.nlm.nih.gov/pubmed/27542271 http://dx.doi.org/10.18632/oncotarget.11325

Ejemplares similares

LAPTM4B-35, a Cancer-Related Gene, Is Associated with Poor Prognosis in TNM Stages I-III Gastric Cancer Patients
por: Cheng, Xiaojing, et al.
Publicado: (2015)

Relationship Between LAPTM4B Gene Polymorphism and Susceptibility of Malignant Melanoma in Chinese Patients
por: Zhang, Meng, et al.
Publicado: (2014)

LAPTM4B*2 allele is associated with the development of papillary thyroid carcinoma in Chinese women
por: Meng, Yue, et al.
Publicado: (2017)

Overexpression of LAPTM4B-35: A Novel Marker of Poor Prognosis of Prostate Cancer
por: Zhang, Hongtuan, et al.
Publicado: (2014)

Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer
por: Kong, Fanming, et al.
Publicado: (2016)

Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis
por: Zhou, Linghui, et al.
Publicado: (2018)

miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression
por: Zhang, Hongtuan, et al.
Publicado: (2015)

LAPTM4B-35 protein is a weak tumor-associated antigen candidate
por: SHI, GUILAN, et al.
Publicado: (2014)

Down-regulation of LAPTM5 in human cancer cells
por: Nuylan, Michelle, et al.
Publicado: (2016)

LAPTM4B promotes the progression of nasopharyngeal cancer
por: Su, Qun, et al.
Publicado: (2021)

LAPTM4B polymorphism increases susceptibility to multiple cancers in Chinese populations: a meta-analysis
por: Mo, Cuiju, et al.
Publicado: (2014)

Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination
por: Pak, Youngshil, et al.
Publicado: (2006)

LAPTM4B promotes the progression of bladder cancer by stimulating cell proliferation and invasion
por: Yin, Yanhua, et al.
Publicado: (2021)

LAPTM4B Allele *2 Is Associated with Breast Cancer Susceptibility and Prognosis
por: Li, Xiaoyan, et al.
Publicado: (2012)

LAPTM4B‐35 promotes cancer cell migration via stimulating integrin beta1 recycling and focal adhesion dynamics
por: Liu, Minxia, et al.
Publicado: (2022)

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
por: Li, Yang, et al.
Publicado: (2010)

Long Noncoding RNA HCAL Facilitates the Growth and Metastasis of Hepatocellular Carcinoma by Acting as a ceRNA of LAPTM4B
por: Xie, Cheng-Rong, et al.
Publicado: (2017)

Overexpression of LAPTM4B-35 is a negative prognostic factor in head and neck squamous cell carcinoma
por: Kotowski, Ulana, et al.
Publicado: (2019)

LAPTM4B-35 expression is associated with pathological grades and clinical stages in salivary adenoid cystic carcinoma
por: Fan, Jianlin, et al.
Publicado: (2020)

LAPTM4B facilitates tumor growth and induces autophagy in hepatocellular carcinoma
por: Wang, Fei, et al.
Publicado: (2019)

AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity
por: Meng, Yue, et al.
Publicado: (2018)

LAPTM4B knockdown increases the radiosensitivity of EGFR-overexpressing radioresistant nasopharyngeal cancer cells by inhibiting autophagy
por: Chu, Chu, et al.
Publicado: (2019)

Serum LAPTM4B as a Potential Diagnostic and Prognostic Biomarker for Breast Cancer
por: Wang, Lu, et al.
Publicado: (2022)

The relationship between LAPTM4B polymorphisms and cancer risk in Chinese Han population: a meta-analysis
por: Xia, Ling-Zi, et al.
Publicado: (2015)

miR-137–LAPTM4B regulates cytoskeleton organization and cancer metastasis via the RhoA-LIMK-Cofilin pathway in osteosarcoma
por: Yan, Ruyu, et al.
Publicado: (2023)

LAPTM4B Gene Expression and Polymorphism as Diagnostic Markers of Breast Cancer in Egyptian Patients
por: Shaker, Olfat, et al.
Publicado: (2015)

Spine-specific downregulation of LAPTM5 expression promotes the progression and spinal metastasis of estrogen receptor-positive breast cancer by activating glutamine-dependent mTOR signaling
por: Meng, Qingbing, et al.
Publicado: (2022)

Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages
por: Zhao, Li, et al.
Publicado: (2021)

Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients
por: Li, Sha, et al.
Publicado: (2017)

LAPTM4B gene polymorphism augments the risk of cancer: Evidence from an updated meta‐analysis
por: Hashemi, Mohammad, et al.
Publicado: (2018)

LAPTM4B: an oncogene in various solid tumors and its functions
por: Meng, Y, et al.
Publicado: (2016)

LAPTM5–CD40 Crosstalk in Glioblastoma Invasion and Temozolomide Resistance
por: Berberich, Anne, et al.
Publicado: (2020)

Repulsive guidance molecule B inhibits metastasis and is associated with decreased mortality in non-small cell lung cancer
por: Li, Jin, et al.
Publicado: (2016)

LAPTM5 Plays a Key Role in the Diagnosis and Prognosis of Testicular Germ Cell Tumors
por: Li, Xiunan, et al.
Publicado: (2021)

Lentivirus-mediated knockdown of NLK inhibits small-cell lung cancer growth and metastasis
por: Lv, Mutian, et al.
Publicado: (2016)

LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells
por: Maki, Yuho, et al.
Publicado: (2015)

LAPTM5 is transactivated by RUNX2 and involved in RANKL trafficking in osteoblastic cells
por: Geng, Yuan-Ming, et al.
Publicado: (2019)

LAPTM5 Restricts HIV-1 Infection in Dendritic Cells and Is Counteracted by Vpr
por: Ouyang, Jiayue, et al.
Publicado: (2022)

The combination of decitabine and aspirin inhibits tumor growth and metastasis in non-small cell lung cancer
por: Xu, Maoyi, et al.
Publicado: (2022)

Correction for Morton et al., Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1nvhr4q9pnl1a7eohs7401kl94